This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1978 Jan 14;1(8055):105.

doi: 10.1016/s0140-6736(78)90053-3.

Safety of tamoxifen

J S Patterson, M Baum

PMID: 74554
DOI: 10.1016/s0140-6736(78)90053-3

Safety of tamoxifen

J S Patterson et al. Lancet. 1978.

. 1978 Jan 14;1(8055):105.

doi: 10.1016/s0140-6736(78)90053-3.

Authors

J S Patterson, M Baum

PMID: 74554
DOI: 10.1016/s0140-6736(78)90053-3

No abstract available

PubMed Disclaimer

Similar articles

Tamoxifen: toxicities and drug resistance during the treatment and prevention of breast cancer.
Jordan VC. Jordan VC. Annu Rev Pharmacol Toxicol. 1995;35:195-211. doi: 10.1146/annurev.pa.35.040195.001211. Annu Rev Pharmacol Toxicol. 1995. PMID: 7598491 Review.
Determination of tamoxifen--DNA adducts in leukocytes from breast cancer patients treated with tamoxifen.
Umemoto A, Monden Y, Lin CX, Abdul-Momen M, Ueyama Y, Komaki K, Laxmi YR, Shibutani S. Umemoto A, et al. Chem Res Toxicol. 2004 Dec;17(12):1577-83. doi: 10.1021/tx049930c. Chem Res Toxicol. 2004. PMID: 15606132
AFPep, a novel drug for the prevention and treatment of breast cancer, does not disrupt the estrous cycle or fertility in rats.
Tower AM, Trinward A, Lee K, Joseph L, Jacobson HI, Bennett JA, Andersen TT. Tower AM, et al. Oncol Rep. 2009 Jul;22(1):49-56. doi: 10.3892/or_00000405. Oncol Rep. 2009. PMID: 19513504
Use of tamoxifen for breast cancer: twenty-eight years later.
Jaiyesimi IA, Buzdar AU, Decker DA, Hortobagyi GN. Jaiyesimi IA, et al. J Clin Oncol. 1995 Feb;13(2):513-29. doi: 10.1200/JCO.1995.13.2.513. J Clin Oncol. 1995. PMID: 7844613 Review.
Inhibition of vacuolar H+ ATPase enhances sensitivity to tamoxifen via up-regulation of CHOP in breast cancer cells.
Jin HO, Lee YH, Kim HA, Kim EK, Noh WC, Kim YS, Hwang CS, Kim JI, Chang YH, Hong SI, Hong YJ, Park IC, Lee JK. Jin HO, et al. Biochem Biophys Res Commun. 2013 Aug 2;437(3):463-8. doi: 10.1016/j.bbrc.2013.06.106. Epub 2013 Jul 6. Biochem Biophys Res Commun. 2013. PMID: 23838288

See all similar articles

Cited by

Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer.
Heel RC, Brogden RN, Speight TM, Avery GS. Heel RC, et al. Drugs. 1978 Jul;16(1):1-24. doi: 10.2165/00003495-197816010-00001. Drugs. 1978. PMID: 352663 Review.
Phase I clinical and pharmacokinetics study of high-dose toremifene in postmenopausal patients with advanced breast cancer.
Bishop J, Murray R, Webster L, Pitt P, Stokes K, Fennessy A, Olver I, Leber G. Bishop J, et al. Cancer Chemother Pharmacol. 1992;30(3):174-8. doi: 10.1007/BF00686307. Cancer Chemother Pharmacol. 1992. PMID: 1385761 Clinical Trial.
Tamoxifen and liver damage.
Blackburn AM, Amiel SA, Millis RR, Rubens RD. Blackburn AM, et al. Br Med J (Clin Res Ed). 1984 Aug 4;289(6440):288. doi: 10.1136/bmj.289.6440.288. Br Med J (Clin Res Ed). 1984. PMID: 6430441 Free PMC article. No abstract available.
Estrogens and antiestrogens stimulate release of bone resorbing activity by cultured human breast cancer cells.
Valentin-Opran A, Eilon G, Saez S, Mundy GR. Valentin-Opran A, et al. J Clin Invest. 1985 Feb;75(2):726-31. doi: 10.1172/JCI111753. J Clin Invest. 1985. PMID: 3855865 Free PMC article.
A risk-benefit assessment of tamoxifen therapy.
Catherino WH, Jordan VC. Catherino WH, et al. Drug Saf. 1993 May;8(5):381-97. doi: 10.2165/00002018-199308050-00005. Drug Saf. 1993. PMID: 8504018 Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science